<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a condition in which the <z:mpath ids='MPATH_458'>normal</z:mpath> stratified squamous epithelium of the distal esophagus is replaced by <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>For more than three decades, the prevailing clinical paradigm has been that <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a complication of symptomatic reflux disease that predisposes to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>However, no clinical strategy for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention or early detection based on this paradigm has been proven to reduce esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> mortality in a randomized clinical trial in part because only about 5% to 10% of individuals with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> develop esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Recent research indicates that Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> is an adaptation for mucosal defense in response to <z:hpo ids='HP_0011010'>chronic</z:hpo> reflux in most individuals </plain></SENT>
<SENT sid="4" pm="."><plain>The risk of progressing to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is determined by development of genomic instability and dynamic <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> in the distal esophagus modulated by host and environmental risk and protective factors, including inherited genotype </plain></SENT>
<SENT sid="5" pm="."><plain>The challenge for investigators of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> lies in integrating knowledge about genomic instability and <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> into clinical management to increase the lifespan and quality of life of individuals with this condition </plain></SENT>
</text></document>